Your browser doesn't support javascript.
loading
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
Scholte, Mirre; Ramaekers, Bram; Danopoulos, Evangelos; Grimm, Sabine E; Fernandez Coves, Andrea; Tian, Xiaoyu; Debray, Thomas; Chen, Jiongyu; Stirk, Lisa; Croft, Rachel; Joore, Manuela; Armstrong, Nigel.
Affiliation
  • Scholte M; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands. mirre.scholte@mumc.nl.
  • Ramaekers B; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. mirre.scholte@mumc.nl.
  • Danopoulos E; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Grimm SE; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Fernandez Coves A; Kleijnen Systematic Reviews (KSR) Ltd, York, UK.
  • Tian X; Statistical Laboratory, Department of Pure Mathematics and Mathematical Statistics, University of Cambridge, Cambridge, UK.
  • Debray T; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Chen J; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Stirk L; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Croft R; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Joore M; Kleijnen Systematic Reviews (KSR) Ltd, York, UK.
  • Armstrong N; Smart Data Analysis and Statistics B.V., Utrecht, The Netherlands.
Pharmacoeconomics ; 42(8): 829-832, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38717708

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Technology Assessment, Biomedical / Cost-Benefit Analysis / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Technology Assessment, Biomedical / Cost-Benefit Analysis / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Netherlands